These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

312 related items for PubMed ID: 16010109

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Treatment of masseteric hypertrophy with botulinum toxin: a report of two cases.
    Baş B, Ozan B, Muğlali M, Celebi N.
    Med Oral Patol Oral Cir Bucal; 2010 Jul 01; 15(4):e649-52. PubMed ID: 20173718
    [Abstract] [Full Text] [Related]

  • 6. Effect of botulinum toxin type A injection into human masseter muscle on stimulated parotid saliva flow rate.
    Kwon JS, Kim ST, Jeon YM, Choi JH.
    Int J Oral Maxillofac Surg; 2009 Apr 01; 38(4):316-20. PubMed ID: 19231136
    [Abstract] [Full Text] [Related]

  • 7. Botulinum toxin as an alternative for the treatment of aesthetic deformities.
    Barbosa MV, Nahas FX, Ferreira LM, Al-Ahmad HT, Al-Qudah M.
    Saudi Med J; 2006 Oct 01; 27(10):1613; author reply 1613. PubMed ID: 17013500
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Treatment of unilateral masseteric hypertrophy with botulinum toxin: case report.
    Mandel L, Tharakan M.
    J Oral Maxillofac Surg; 1999 Aug 01; 57(8):1017-9. PubMed ID: 10437733
    [No Abstract] [Full Text] [Related]

  • 10. Lower facial contouring with botulinum toxin type A.
    Tartaro G, Rauso R, Santagata M, Santillo V, Itro A.
    J Craniofac Surg; 2008 Nov 01; 19(6):1613-7. PubMed ID: 19098563
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effects of botulinum toxin type A on contouring of the lower face.
    Choe SW, Cho WI, Lee CK, Seo SJ.
    Dermatol Surg; 2005 May 01; 31(5):502-7; discussion 507-8. PubMed ID: 15962731
    [Abstract] [Full Text] [Related]

  • 14. Botulinum toxin type A in the management of masseter muscle hypertrophy.
    Castro WH, Gomez RS, Da Silva Oliveira J, Moura MD, Gomez RS.
    J Oral Maxillofac Surg; 2005 Jan 01; 63(1):20-4. PubMed ID: 15635552
    [Abstract] [Full Text] [Related]

  • 15. Evaluation and selecting indications for the treatment of improving facial morphology by masseteric injection of botulinum toxin type A.
    Gaofeng L, Jun T, Bo P, Bosheng Z, Qian Z, Dongping L.
    J Plast Reconstr Aesthet Surg; 2010 Dec 01; 63(12):2026-31. PubMed ID: 20116356
    [Abstract] [Full Text] [Related]

  • 16. Botulinum toxin for masseter hypertrophy.
    Al-Muharraqi MA, Fedorowicz Z, Al Bareeq J, Al Bareeq R, Nasser M.
    Cochrane Database Syst Rev; 2009 Jan 21; (1):CD007510. PubMed ID: 19160335
    [Abstract] [Full Text] [Related]

  • 17. Effects of botulinum toxin type A on bilateral masseteric hypertrophy evaluated with computed tomographic measurement.
    Kim HJ, Yum KW, Lee SS, Heo MS, Seo K.
    Dermatol Surg; 2003 May 21; 29(5):484-9. PubMed ID: 12752515
    [Abstract] [Full Text] [Related]

  • 18. Botox facial slimming/facial sculpting: the role of botulinum toxin-A in the treatment of hypertrophic masseteric muscle and parotid enlargement to narrow the lower facial width.
    Wu WT.
    Facial Plast Surg Clin North Am; 2010 Feb 21; 18(1):133-40. PubMed ID: 20206096
    [Abstract] [Full Text] [Related]

  • 19. The medical management of masseteric hypertrophy with botulinum toxin type A.
    Moore AP, Wood GD.
    Br J Oral Maxillofac Surg; 1994 Feb 21; 32(1):26-8. PubMed ID: 8136334
    [Abstract] [Full Text] [Related]

  • 20. Commentary.
    De Almeida AR.
    Dermatol Surg; 2009 Dec 21; 35(12):1907. PubMed ID: 20050146
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.